Cargando…

Biomarkers of Tumor Heterogeneity in Glioblastoma Multiforme Cohort of TCGA

SIMPLE SUMMARY: Identifying biomarkers of survival from a large-scale cohort of Glioblastoma Multiforme (GBM) pathology images is hindered by heterogeneity of tumor signature compounded by age being the single most important confounder in predicting survival in GBM. The main contributions of this ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winkelmaier, Garrett, Koch, Brandon, Bogardus, Skylar, Borowsky, Alexander D., Parvin, Bahram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137245/ https://www.ncbi.nlm.nih.gov/pubmed/37190318 http://dx.doi.org/10.3390/cancers15082387

Ejemplares similares

Morphometic analysis of TCGA glioblastoma multiforme
por: Chang, Hang, et al.
Publicado: (2011)

Fusion of encoder-decoder deep networks improves delineation of multiple nuclear phenotypes
por: Khoshdeli, Mina, et al.
Publicado: (2018)

CD36(+) Fibroblasts Secrete Protein Ligands That Growth-Suppress Triple-Negative Breast Cancer Cells While Elevating Adipogenic Markers for a Model of Cancer-Associated Fibroblast
por: Jabbari, Kosar, et al.
Publicado: (2022)

Biomarkers for glioblastoma multiforme: status quo
por: Montano, Nicola, et al.
Publicado: (2016)

Influence of Simulated Microgravity on Mammary Epithelial Cells Grown as 2D and 3D Cultures
por: Winkelmaier, Garrett, et al.
Publicado: (2023)

Glioblastoma Multiforme: A Look Inside Its Heterogeneous Nature
por: Inda, Maria-del-Mar, et al.
Publicado: (2014)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Prostate-Specific Membrane Antigen Expression in Neovasculature of Glioblastoma Multiforme
por: Mahzouni, Parvin, et al.
Publicado: (2019)

Membranome Similarity between Glioblastoma Multiforme Cell Lines and Primary Tumors
por: Batchu, Sai, et al.
Publicado: (2023)

Genomic and Epigenomic Features of Glioblastoma Multiforme and its Biomarkers
por: Jadoon, Sarmad Sheraz, et al.
Publicado: (2022)

Protein Ligands in the Secretome of CD36(+) Fibroblasts Induce Growth Suppression in a Subset of Breast Cancer Cell Lines
por: Jabbari, Kosar, et al.
Publicado: (2021)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme
por: Xavier, Mary-Ann, et al.
Publicado: (2021)

Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

Glioblastoma multiforme: a multi-omics analysis of driver genes and tumour heterogeneity
por: Herrera-Oropeza, Gabriel Emilio, et al.
Publicado: (2021)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007)

The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis
por: Bergmann, Natalie, et al.
Publicado: (2020)

Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA
por: Yang, Qi, et al.
Publicado: (2018)

Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment
por: Kumari, Smita, et al.
Publicado: (2023)

Targeting cellular pathways in glioblastoma multiforme
por: Pearson, Joshua R D, et al.
Publicado: (2017)

Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme
por: Onishi, Manabu, et al.
Publicado: (2013)

GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma Multiforme
por: Zimmer, Niklas, et al.
Publicado: (2019)

Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells
por: Peñas-Martínez, Julia, et al.
Publicado: (2021)

Drug repurposing for the treatment of glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_36tme2fvu0k5vflhlquudo61dj